首页> 外文期刊>Hepato-gastroenterology. >Alpha-fetoprotein: The predictor of microvascular invasion in solitary small hepatocellular carcinoma and criterion for anatomic or non-anatomic hepatic resection
【24h】

Alpha-fetoprotein: The predictor of microvascular invasion in solitary small hepatocellular carcinoma and criterion for anatomic or non-anatomic hepatic resection

机译:甲胎蛋白:孤立性小肝细胞癌微血管侵袭的预测因子和解剖或非解剖肝切除的标准

获取原文
获取原文并翻译 | 示例
       

摘要

Background/Aims: This study aimed to identify the preoperative predictors of microvascular invasion (MVI) in solitary small hepatocellular carcinoma (HCC) and evaluate their application in surgical treatment. Methodology: We retrospectively analyzed 161 patients with solitary small HCC who underwent curative hepatic resection. Overall and disease-free survival rates were calculated by Kaplan-Meier method and compared by log-rank test. The independent predictors were identified by Cox proportional hazards model. Results: MVI was an independent predictor of both overall and disease-free survival. In 51 patients with MVI, anatomic resection achieved better survival than non-anatomic resection. However, anatomic resection and non-anatomic resection brought similar survival in patients without MVI. Alpha-fetoprotein (AFP) was identified as the unique predictor of MVI (HR=2.773, p=0.004). Anatomic resection achieved better survival outcome than non-anatomic resection when AFP >100μg/L (5-year overall survival rate: 85% vs. 55%, p=0.024; 5-year disease-free survival rate: 37% vs. 21%, p=0.025), while there was no statistical survival difference between anatomic and non-anatomic resection when AFP ≤100μg/L (5-year overall survival rate: 85% vs. 76%, p=0.838; 5-year disease-free survival rate: 48% vs. 49%, p=0.921). Conclusions: Compared with non-anatomic resection, anatomic hepatic resection improves overall and disease-free survival of solitary small HCC patients with AFP >100μg/L.
机译:背景/目的:本研究旨在确定孤立性小肝细胞癌(HCC)中微血管浸润(MVI)的术前预测指标,并评估其在外科治疗中的应用。方法:我们回顾性分析了行根治性肝切除的161例孤立性小肝癌患者。通过Kaplan-Meier方法计算总体生存率和无病生存率,并通过对数秩检验进行比较。通过Cox比例风险模型确定独立的预测因素。结果:MVI是整体和无病生存的独立预测指标。在51例MVI患者中,解剖切除术比非解剖切除术具有更好的生存率。但是,无MVI的患者,解剖切除和非解剖切除的生存率相似。甲胎蛋白(AFP)被确定为MVI的唯一预测因子​​(HR = 2.773,p = 0.004)。当AFP>100μg/ L时,解剖切除术比非解剖切除术具有更好的生存结果(5年总生存率:85%对55%,p = 0.024; 5年无病生存率:37%对21 %,p = 0.025),而当AFP≤100μg/ L时,解剖切除与非解剖切除的生存率无统计学差异(5年总生存率:85%vs. 76%,p = 0.838; 5年疾病生存率:48%和49%,p = 0.921)。结论:与非解剖切除相比,解剖肝切除可改善AFP>100μg/ L的单独小型HCC患者的总体生存率和无病生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号